{"id":8977,"date":"2021-12-17T03:41:11","date_gmt":"2021-12-17T08:41:11","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/puya-supply-top-grade-semaglutide-cas-910463-68-2-kaytto-tyypin-2-diabeteksen-hoitoon\/"},"modified":"2021-12-17T03:41:11","modified_gmt":"2021-12-17T08:41:11","slug":"puya-supply-top-grade-semaglutide-cas-910463-68-2-kaytto-tyypin-2-diabeteksen-hoitoon","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/fi\/product\/puya-supply-top-grade-semaglutide-cas-910463-68-2-kaytto-tyypin-2-diabeteksen-hoitoon\/","title":{"rendered":"Puya Supply Top Grade Semaglutide Cas 910463-68-2 K\u00e4ytt\u00f6 tyypin 2 diabeteksen hoitoon"},"content":{"rendered":"

Puya Supply Top Grade Semaglutide Cas 910463-68-2 K\u00e4ytt\u00f6 tyypin 2 diabeteksen hoitoon<\/strong><\/h2>\n

Tuotteen nimi: Sermaglutidi
\nSynonyymit: Sermaglutide;Semaglutide fandachem;Semaglutide-ep\u00e4puhtaus;Sermaglutidi USP\/EP\/BP;semaglutidi;Sermaglutidi CAS 910463 68 2
\nCAS: 910463-68-29N58>MF28-2918
\nMW: 4113.57754
\nEINECS: 203-405-2
\nTuoteluokat: GLP;PP;API;API
\nMol Tiedosto: 910463-68-2.mol
\nPakkauskoko 1g\/pullo , 10g\/pullo,50g\/pullo tai asiakkaan pyynn\u00f6st\u00e4<\/p>\n

Semaglutide on uuden sukupolven GLP-1 (glukagonin kaltainen peptidi-1) analogeja. Semaglutidi on liraglutidin perusrakenteeseen perustuva pitk\u00e4vaikutteinen annosmuoto, joka on tehokkaampi tyypin 2 diabeteksen hoidossa. Lilarlutidiin verrattuna somalutidilla on pidempi alifobinen ketju ja lis\u00e4\u00e4ntynyt hydrofobisuus, mutta somalutidia modifioidaan lyhyell\u00e4 PEG-ketjulla ja sen hydrofiilisyys paranee huomattavasti.PEG-modifikaatio ei voi vain sitoutua tiukasti albumiiniin, vaan se peitt\u00e4\u00e4 DPP-4-entsymaattisen hydrolyysikohtaa, mutta my\u00f6s v\u00e4hent\u00e4\u00e4 munuaisten erittymist\u00e4, pident\u00e4\u00e4 biologista puoliintumisaikaa ja saavuttaa pitk\u00e4n verenkierron vaikutus.<\/p>\n

Toiminta ja<\/strong> k\u00e4ytt\u00f6
\nSemaglutidi (USAN; kauppanimi Ozempic) on kehitteill\u00e4 oleva farmaseuttinen l\u00e4\u00e4keaine tanskalaisen Novo Nordiskin toimesta tyypin 2 diabeteksen hoitoon. Sit\u00e4 markkinoidaan nimell\u00e4 Ozempic. Glukagonin kaltaisena peptidi-1-reseptorin agonistina se alentaa verensokeritasoa lis\u00e4\u00e4m\u00e4ll\u00e4 in.suliinin tuotantoa. Novo Nordiskin tutkijaryhm\u00e4 l\u00f6ysi sen vuonna 2012 pidempivaikutteisena vaihtoehdona liraglutidille. Kliiniset kokeet aloitettiin vuonna 2015 ja vaihe 3 valmistui vuonna 2016. FDA:n hyv\u00e4ksynt\u00e4 haettiin joulukuussa 2016, ja lokakuussa 2017 FDA:n neuvoa-antava komitea \u00e4\u00e4nesti 16-0 puolesta. Sit\u00e4 voidaan k\u00e4ytt\u00e4\u00e4 sek\u00e4 injektio- ett\u00e4 oraalityyppisen\u00e4 l\u00e4\u00e4kkeen\u00e4.
\nLeedsin yliopiston tutkijat raportoivat vuonna 2017, ett\u00e4 sit\u00e4 voidaan k\u00e4ytt\u00e4\u00e4 my\u00f6s liikalihavuuden hoitoon. Se v\u00e4hent\u00e4\u00e4 n\u00e4lk\u00e4\u00e4, ruokahalua ja kehon rasvaa.<\/p>\n","protected":false},"excerpt":{"rendered":"

Tuotteen nimi: Sermaglutide
\nCAS: 910463-68-2
\nMF: C187H291N45O59
\nMW: 4113.57754
\nEINECS: 203-405-2
\nTuoteluokat: GLPAP;PP;APIs; &> Mol Tiedosto: 910463-68-2.mol<\/p>\n","protected":false},"featured_media":2100,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[340],"product_tag":[789,767],"class_list":{"0":"post-8977","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-diabetes-peptidi","7":"product_tag-cas-910463-68-2-fi","8":"product_tag-semaglutide-fi","9":"desktop-align-left","10":"tablet-align-left","11":"mobile-align-left","13":"first","14":"instock","15":"shipping-taxable","16":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product\/8977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/comments?post=8977"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media\/2100"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/media?parent=8977"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_brand?post=8977"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_cat?post=8977"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/fi\/wp-json\/wp\/v2\/product_tag?post=8977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}